arnuity ellipta

Generic: fluticasone furoate

Labeler: glaxosmithkline llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name arnuity ellipta
Generic Name fluticasone furoate
Labeler glaxosmithkline llc
Dosage Form POWDER
Routes
RESPIRATORY (INHALATION)
Active Ingredients

fluticasone furoate 200 ug/1

Manufacturer
GlaxoSmithKline LLC

Identifiers & Regulatory

Product NDC 0173-0876
Product ID 0173-0876_99087493-3503-425e-91e3-ba430d16104f
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA205625
Listing Expiration 2026-12-31
Marketing Start 2014-08-20

Pharmacologic Class

Classes
corticosteroid hormone receptor agonists [moa] corticosteroid [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01730876
Hyphenated Format 0173-0876

Supplemental Identifiers

RxCUI
1547658 1547660 1547663 1547664 1547666 1547668 1547671 1547672 2045377 2045382
UNII
JS86977WNV

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name arnuity ellipta (source: ndc)
Generic Name fluticasone furoate (source: ndc)
Application Number NDA205625 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 200 ug/1
source: ndc
Packaging
  • 1 INHALER in 1 CARTON (0173-0876-10) / 30 POWDER in 1 INHALER
  • 1 INHALER in 1 CARTON (0173-0876-14) / 14 POWDER in 1 INHALER
source: ndc

Packages (2)

Ingredients (1)

fluticasone furoate (200 ug/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "99087493-3503-425e-91e3-ba430d16104f", "openfda": {"unii": ["JS86977WNV"], "rxcui": ["1547658", "1547660", "1547663", "1547664", "1547666", "1547668", "1547671", "1547672", "2045377", "2045382"], "spl_set_id": ["50f193ee-1691-486d-9370-a664df63695c"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 INHALER in 1 CARTON (0173-0876-10)  / 30 POWDER in 1 INHALER", "package_ndc": "0173-0876-10", "marketing_start_date": "20140820"}, {"sample": false, "description": "1 INHALER in 1 CARTON (0173-0876-14)  / 14 POWDER in 1 INHALER", "package_ndc": "0173-0876-14", "marketing_start_date": "20140820"}], "brand_name": "Arnuity Ellipta", "product_id": "0173-0876_99087493-3503-425e-91e3-ba430d16104f", "dosage_form": "POWDER", "pharm_class": ["Corticosteroid Hormone Receptor Agonists [MoA]", "Corticosteroid [EPC]"], "product_ndc": "0173-0876", "generic_name": "fluticasone furoate", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Arnuity Ellipta", "active_ingredients": [{"name": "FLUTICASONE FUROATE", "strength": "200 ug/1"}], "application_number": "NDA205625", "marketing_category": "NDA", "marketing_start_date": "20140820", "listing_expiration_date": "20261231"}